Cyberonics VNS Depression Treatment Panel Review Tentatively Set For June
This article was originally published in The Gray Sheet
Executive Summary
FDA's Neurological Devices Advisory Panel will review a PMA supplement for Cyberonics' VNS Therapy depression indication June 15, the firm says